Conversion to Complete Resection with mFOLFOX6 with Bevacizumab or Cetuximab Based on K-RAS Status for Unresectable Colorectal Liver Metastasis (BECK study): Long-Term Results of Survival.
暂无分享，去创建一个
E. Hatano | S. Uemoto | Kojiro Nakamura | T. Horimatsu | K. Yasuchika | T. Ishii | H. Nishino | Y. Sakai | S. Hasegawa | D. Manaka | M. Zaima | A. Kanazawa | S. Matsumoto | K. Taura | S. Kaihara | S. Seo | K. Furumoto | H. Terajima | A. Tokuka | T. Hirose | Takefumi Yazawa | Rei Toda | M. Okuno | N. Inoue | H. Furuyama | K. Doi | Y. Adachi